-
1دورية أكاديمية
المؤلفون: Zeng Y; Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China.; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China., Liu J; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China., Wang W; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China., Wang B; Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China., Jia A; Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou 570311, China.
المصدر: Journal of applied microbiology [J Appl Microbiol] 2024 Sep 02; Vol. 135 (9).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9706280 Publication Model: Print Cited Medium: Internet ISSN: 1365-2672 (Electronic) Linking ISSN: 13645072 NLM ISO Abbreviation: J Appl Microbiol Subsets: MEDLINE
مواضيع طبية MeSH: Biofilms*/drug effects , Biofilms*/growth & development , Aeromonas hydrophila*/drug effects , Aeromonas hydrophila*/pathogenicity , Aeromonas hydrophila*/physiology , Virulence Factors*/metabolism , Dactinomycin*/pharmacology , Quorum Sensing*/drug effects, Virulence/drug effects ; Anti-Bacterial Agents/pharmacology ; Animals ; Microbial Sensitivity Tests
-
2دورية أكاديمية
المؤلفون: Murphy AJ; Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA. andrew.murphy@stjude.org.; Division of Pediatric Surgery, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, USA. andrew.murphy@stjude.org.
المصدر: British journal of cancer [Br J Cancer] 2024 Oct; Vol. 131 (6), pp. 970-971. Date of Electronic Publication: 2024 Aug 27.
نوع المنشور: Journal Article; Editorial
بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Wilms Tumor*/drug therapy , Wilms Tumor*/pathology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/pathology , Vincristine*/administration & dosage , Vincristine*/therapeutic use , Dactinomycin*/administration & dosage , Dactinomycin*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Child ; Treatment Outcome ; Child, Preschool
-
3دورية أكاديمية
المؤلفون: Sudour-Bonnange H; Department of Children and AYA Oncology, Centre Oscar Lambret, Lille, France. h-sudour@o-lambret.fr., van Tinteren H; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Ramírez-Villar GL; Department of Pediatric Oncology, Hospital Universitario Virgen Del Rocio, Sevilla, Spain., Godzinski J; Department of Pediatric Surgery, Marciniak Hospital, Fieldorfa 2 and Department of Pediatric Traumatology and Emergency Medicine, Wroclaw Medical university, Wrocław, Poland., Irtan S; Department of Pediatric Surgery, Hospital Trousseau, Paris, France., Gessler M; Theosor-Boveri Institute/Biocenter and Comprehensive Cancer Center Mainfranken, University of Wuerzburg, Würzburg, Germany., Chowdhury T; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Audry G; Department of Pediatric Surgery, Hospital Trousseau, Paris, France., Fuchs J; Department of Pediatric Surgery and Urology, University Hospital Tübingen, 72076, Tuebingen, Germany., Powis M; Department of Pediatric Surgery, Leeds Teaching Hospital NHS Trust, Leeds, UK., van de Ven CP; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Okoye B; Department of Paediatric Surgery, St George's University Hospital, London, UK., Smeulders N; Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK., Vujanic GM; Department of Pathology, Sidra Medicine and weill Cornell Medicine- Qatar, Doha, Qatar., Verschuur A; Department of Pediatric Hemato-Oncology, Hospital La Timone, Marseille, France., L'Herminé-Coulomb A; Department of Pathology; Hospital Trousseau, Paris, France., de Camargo B; Pediatric Hematology and Oncology program, research Center, Instituto National de Cancer, Rio de Janeiro, Brazil., de Aguirre Neto JC; Department of Pediatric Hematology and Oncology, Hospital Santa Casa Belo-Horizonte, Belo Horizonte, Brazil., Schenk JP; Sektion Pädiatrische Radiologie, Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland., van den Heuvel-Eibrink MM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhealth, Wilhelmina Children's Hospital, Utrecht, the Netherlands., Pritchard-Jones K; Developmental Biology and Cancer Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, UK., Graf N; Saarland University, Homburg, Germany., Bergeron C; Department of Pediatric Oncology and Hematology, Centre Léon Berard, Lyon, France., Furtwängler R; Saarland University, Homburg, Germany.; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital, University Bern, Bern, Switzerland.
المصدر: British journal of cancer [Br J Cancer] 2024 Oct; Vol. 131 (6), pp. 972-981. Date of Electronic Publication: 2024 Jul 30.
نوع المنشور: Clinical Study; Journal Article
بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Dactinomycin*/administration & dosage , Dactinomycin*/therapeutic use , Kidney Neoplasms*/pathology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/surgery , Kidney Neoplasms*/therapy , Vincristine*/administration & dosage , Vincristine*/therapeutic use , Wilms Tumor*/pathology , Wilms Tumor*/drug therapy , Wilms Tumor*/surgery , Wilms Tumor*/therapy, Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Chemotherapy, Adjuvant ; Neoadjuvant Therapy ; Neoplasms, Multiple Primary/pathology ; Neoplasms, Multiple Primary/drug therapy ; Neoplasms, Multiple Primary/surgery ; Nephrectomy/methods ; Treatment Outcome
SCR Protocol: SIOP protocol
-
4دورية أكاديمية
المؤلفون: Yang H; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Li S; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Li W; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Yang Y; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Zhang Y; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Zhang S; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Hao Y; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Cao W; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Xu F; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Wang H; Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, 300060, Tianjin, China., Du G; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China., Wang J; The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.; Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
المصدر: Carcinogenesis [Carcinogenesis] 2024 Apr 12; Vol. 45 (4), pp. 262-273.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print Cited Medium: Internet ISSN: 1460-2180 (Electronic) Linking ISSN: 01433334 NLM ISO Abbreviation: Carcinogenesis Subsets: MEDLINE
مواضيع طبية MeSH: Dactinomycin*/pharmacology , Dactinomycin*/metabolism , Dactinomycin*/therapeutic use , Doxorubicin*/pharmacology , Triple Negative Breast Neoplasms*/drug therapy, Animals ; Humans ; Mice ; Apoptosis/drug effects ; Apoptosis Regulatory Proteins ; Cell Line, Tumor ; Mice, Nude ; RNA, Small Interfering ; Tumor Suppressor Protein p53/drug effects ; Tumor Suppressor Protein p53/metabolism
-
5دورية أكاديمية
المؤلفون: Łasut-Szyszka B; Center for Translational Research and Molecular Biology of Cancer, Gliwice Branch, Maria Skłodowska-Curie National Research Institute of Oncology, ul. Wybrzeże Armii Krajowej 15, Gliwice, 44-101, Poland., Gdowicz-Kłosok A; Center for Translational Research and Molecular Biology of Cancer, Gliwice Branch, Maria Skłodowska-Curie National Research Institute of Oncology, ul. Wybrzeże Armii Krajowej 15, Gliwice, 44-101, Poland., Krześniak M; Center for Translational Research and Molecular Biology of Cancer, Gliwice Branch, Maria Skłodowska-Curie National Research Institute of Oncology, ul. Wybrzeże Armii Krajowej 15, Gliwice, 44-101, Poland., Głowala-Kosińska M; Department of Bone Marrow Transplantation and Onco-Hematology, Gliwice Branch, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, 44-101, Poland., Będzińska A; Center for Translational Research and Molecular Biology of Cancer, Gliwice Branch, Maria Skłodowska-Curie National Research Institute of Oncology, ul. Wybrzeże Armii Krajowej 15, Gliwice, 44-101, Poland., Rusin M; Center for Translational Research and Molecular Biology of Cancer, Gliwice Branch, Maria Skłodowska-Curie National Research Institute of Oncology, ul. Wybrzeże Armii Krajowej 15, Gliwice, 44-101, Poland. Marek.Rusin@gliwice.nio.gov.pl.
المصدر: Apoptosis : an international journal on programmed cell death [Apoptosis] 2024 Oct; Vol. 29 (9-10), pp. 1515-1528. Date of Electronic Publication: 2024 Jul 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 9712129 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-675X (Electronic) Linking ISSN: 13608185 NLM ISO Abbreviation: Apoptosis Subsets: MEDLINE
مواضيع طبية MeSH: Dactinomycin*/pharmacology , Imidazoles*/pharmacology , Tumor Suppressor Protein p53*/metabolism , Tumor Suppressor Protein p53*/genetics , Piperazines*/pharmacology , Apoptosis*/drug effects , Drug Resistance, Neoplasm*/drug effects , Drug Resistance, Neoplasm*/genetics , Fas Ligand Protein*/metabolism , Fas Ligand Protein*/genetics, Humans ; Cell Line, Tumor ; Caspases/metabolism ; Caspases/genetics ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/metabolism ; Neoplasms/pathology ; Drug Synergism
-
6دورية أكاديمية
المؤلفون: Zhao W; Medical Oncology Department, Pediatric Oncology CenterNational Center for Children's HealthKey Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing, 100045, China., Zhou Y; Medical Oncology Department, Pediatric Oncology CenterNational Center for Children's HealthKey Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing, 100045, China., Wang X; Medical Oncology Department, Pediatric Oncology CenterNational Center for Children's HealthKey Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing, 100045, China., Yang P; Medical Oncology Department, Pediatric Oncology CenterNational Center for Children's HealthKey Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing, 100045, China., Huang C; Medical Oncology Department, Pediatric Oncology CenterNational Center for Children's HealthKey Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing, 100045, China., Ma X; Medical Oncology Department, Pediatric Oncology CenterNational Center for Children's HealthKey Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing, 100045, China., Su Y; Medical Oncology Department, Pediatric Oncology CenterNational Center for Children's HealthKey Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing, 100045, China. suyanbch@sina.com., Zhang R; Hematology CenterNational Center for Children's HealthKey Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Beijing, 100045, China. ruizh1973@126.com.
المصدر: BMC cancer [BMC Cancer] 2024 Aug 15; Vol. 24 (1), pp. 1013. Date of Electronic Publication: 2024 Aug 15.
نوع المنشور: Journal Article; Clinical Trial
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Sarcoma, Ewing*/drug therapy , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Rhabdomyosarcoma*/drug therapy , Febrile Neutropenia*/prevention & control , Febrile Neutropenia*/chemically induced , Febrile Neutropenia*/etiology , Filgrastim*/therapeutic use , Filgrastim*/administration & dosage , Filgrastim*/adverse effects, Humans ; Male ; Female ; Adolescent ; Child ; Pilot Projects ; Prospective Studies ; Child, Preschool ; Cyclophosphamide/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/therapeutic use ; Dactinomycin/administration & dosage ; Dactinomycin/adverse effects ; Dactinomycin/therapeutic use ; Doxorubicin/adverse effects ; Doxorubicin/administration & dosage ; Infant
-
7دورية أكاديمية
المؤلفون: Mitric C; Division of Gynecologic Oncology, Princess Margaret Cancer Center/University Health Network and Sinai Health System, Toronto, Ontario, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada., Sayyid RK; Department of Surgery, Division of Urology, University of Toronto, Toronto, Ontario, Canada., Fleshner NE; Department of Surgery, Division of Urology, University of Toronto, Toronto, Ontario, Canada., Look Hong NJ; Department of Surgical Oncology, Odette Cancer Centre/ Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Bouchard-Fortier G; Division of Gynecologic Oncology, Princess Margaret Cancer Center/University Health Network and Sinai Health System, Toronto, Ontario, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada. Electronic address: genevieve.bouchard-fortier@uhn.ca.
المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 30-36. Date of Electronic Publication: 2024 May 04.
نوع المنشور: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Hysterectomy*/economics , Cost-Benefit Analysis* , Gestational Trophoblastic Disease*/economics , Gestational Trophoblastic Disease*/drug therapy , Gestational Trophoblastic Disease*/surgery , Quality-Adjusted Life Years* , Markov Chains*, Humans ; Female ; Pregnancy ; Adult ; Antineoplastic Combined Chemotherapy Protocols/economics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Dactinomycin/economics ; Dactinomycin/administration & dosage ; Dactinomycin/therapeutic use ; Methotrexate/economics ; Methotrexate/administration & dosage ; Methotrexate/therapeutic use ; Decision Support Techniques ; Canada ; Cyclophosphamide/economics ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/therapeutic use ; Cost-Effectiveness Analysis
-
8دورية أكاديمية
عنوان ترانسليتريتد: Efectos tardíos del tratamiento del tumor de Wilms.
المؤلفون: Silvente Bernal S; Pediatric Surgery Department. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia (Spain)., Girón Vallejo O; Pediatric Surgery Department. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia (Spain)., Sánchez Sánchez A; Pediatric Surgery Department. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia (Spain)., Menacho Hernández C; Pediatric Surgery Department. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia (Spain)., Rodón Berrío J; Pediatric Surgery Department. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia (Spain)., Parra Gelder BA; Pediatric Surgery Department. Hospital Clínico Universitario Virgen de la Arrixaca. Murcia (Spain).
المصدر: Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica [Cir Pediatr] 2024 Jul 09; Vol. 37 (3), pp. 116-122. Date of Electronic Publication: 2024 Jul 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Pat Ediciones Country of Publication: Spain NLM ID: 8900492 Publication Model: Electronic Cited Medium: Internet ISSN: 2445-2807 (Electronic) Linking ISSN: 02141221 NLM ISO Abbreviation: Cir Pediatr Subsets: MEDLINE
مواضيع طبية MeSH: Wilms Tumor*/drug therapy , Wilms Tumor*/therapy , Kidney Neoplasms*/therapy , Kidney Neoplasms*/drug therapy , Nephrectomy*/methods, Humans ; Male ; Retrospective Studies ; Female ; Infant ; Child, Preschool ; Child ; Quality of Life ; Neoadjuvant Therapy/methods ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Time Factors ; Neoplasms, Second Primary ; Survival Rate ; Dactinomycin/administration & dosage ; Dactinomycin/therapeutic use
-
9دورية أكاديمية
المؤلفون: Gupta AA; Hospital for Sick Children, University of Toronto, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada. Electronic address: abha.gupta@uhn.ca., Xue W; COG Data Center, Gainesville, FL, USA., Harrison DJ; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hawkins DS; Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA., Dasgupta R; Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, USA., Wolden S; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shulkin B; St Jude Children's Research Hospital, Memphis, TN, USA., Qumseya A; COG Data Center, Gainesville, FL, USA., Routh JC; Department of Diagnostic Imaging, Duke University School of Medicine, Durham, NC, USA., MacDonald T; IWK Health Center, Halifax, NS, Canada., Feinberg S; Maimonides Cancer Center at Maimonides Medical Center and Children's Hospital, Brooklyn, NY, USA., Crompton B; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rudzinski ER; Seattle Children's Hospital and University of Washington Medical Center, Seattle, WA, USA., Arnold M; Children's Hospital of Colorado, Aurora, CO, USA., Venkatramani R; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
المصدر: The Lancet. Oncology [Lancet Oncol] 2024 Jul; Vol. 25 (7), pp. 912-921.
نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Sirolimus*/analogs & derivatives , Sirolimus*/administration & dosage , Sirolimus*/therapeutic use , Rhabdomyosarcoma*/drug therapy , Rhabdomyosarcoma*/mortality , Rhabdomyosarcoma*/pathology , Vincristine*/administration & dosage , Vincristine*/adverse effects , Cyclophosphamide*/administration & dosage, Humans ; Male ; Female ; Child ; Adolescent ; Child, Preschool ; Young Adult ; Adult ; Dactinomycin/administration & dosage ; Irinotecan/administration & dosage ; Irinotecan/therapeutic use ; Infant ; Progression-Free Survival ; Forkhead Box Protein O1/genetics
SCR Protocol: VAC protocol
-
10دورية أكاديمية
المؤلفون: Zhou W; Laboratory of Antiallergy Functional Molecules, Zhejiang Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China., Xie Z; Laboratory of Antiallergy Functional Molecules, Zhejiang Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China., Si R; School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China., Chen Z; Laboratory of Antiallergy Functional Molecules, Zhejiang Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China., Javeed A; College of Textile Science and Engineering (International Institute of Silk), Zhejiang Sci-Tech University, Hangzhou 310018, China., Li J; Laboratory of Antiallergy Functional Molecules, Zhejiang Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China., Wu Y; Laboratory of Antiallergy Functional Molecules, Zhejiang Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China., Han B; Laboratory of Antiallergy Functional Molecules, Zhejiang Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 27; Vol. 24 (7). Date of Electronic Publication: 2023 Mar 27.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
مواضيع طبية MeSH: Dactinomycin*/chemistry , Dactinomycin*/pharmacology , Fibroins*/chemistry , Fibroins*/pharmacology , Immobilized Proteins*/chemistry , Immobilized Proteins*/pharmacology , Wound Healing*/drug effects , Antimicrobial Peptides*, Streptomyces/metabolism ; Escherichia coli/drug effects ; Staphylococcus aureus/drug effects ; Spectroscopy, Fourier Transform Infrared ; Microscopy, Atomic Force ; Fermentation ; Materials Testing ; Biocompatible Materials/chemistry ; Biocompatible Materials/pharmacology ; Animals ; Rats ; Male ; Rats, Sprague-Dawley
SCR Organism: Streptomyces cyaneofuscatus